Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Psychiatry Res ; 186(1): 5-10, 2011 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-20817311

RESUMEN

Previous research has suggested that visual hallucinations in schizophrenia are associated with abnormal salience of visual mental images. Since visual imagery is used as a mnemonic strategy to learn lists of words, increased visual imagery might impede the other commonly used strategies of serial and semantic encoding. We had previously published data on the serial and semantic strategies implemented by patients when learning lists of concrete words with different levels of semantic organisation (Brébion et al., 2004). In this paper we present a re-analysis of these data, aiming at investigating the associations between learning strategies and visual hallucinations. Results show that the patients with visual hallucinations presented less serial clustering in the non-organisable list than the other patients. In the semantically organisable list with typical instances, they presented both less serial and less semantic clustering than the other patients. Thus, patients with visual hallucinations demonstrate reduced use of serial and semantic encoding in the lists made up of fairly familiar concrete words, which enable the formation of mental images. Although these results are preliminary, we propose that this different processing of the lists stems from the abnormal salience of the mental images such patients experience from the word stimuli.


Asunto(s)
Alucinaciones/etiología , Recuerdo Mental/fisiología , Esquizofrenia/complicaciones , Semántica , Aprendizaje Verbal , Vocabulario , Adulto , Análisis de Varianza , Femenino , Humanos , Masculino , Pruebas Neuropsicológicas , Estimulación Luminosa/métodos , Escalas de Valoración Psiquiátrica
2.
Biol Psychiatry ; 56(12): 938-42, 2004 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-15601603

RESUMEN

BACKGROUND: Quetiapine improves both psychotic symptoms and cognitive function in schizophrenia. The neural basis of these actions is poorly understood. METHODS: Three subject groups underwent a single functional magnetic resonance imaging (fMRI) session: drug-naive (n = 7) and quetiapine-treated samples of patients with schizophrenia (n = 8) and a healthy control group (n = 8). The fMRI session included an overt verbal fluency task and a passive auditory stimulation task. RESULTS: In the verbal fluency task, there was significantly increased activation in the left inferior frontal cortex in the quetiapine-treated patients and the healthy control sample compared with the drug-naive sample. During auditory stimulation, the healthy control group and stably treated group produced significantly greater activation in the superior temporal gyrus than the drug-naive sample. CONCLUSIONS: Quetiapine treatment is associated with altered blood oxygen level-dependent responses in both the prefrontal and temporal cortex that cannot be accounted for by improved task performance subsequent to drug treatment.


Asunto(s)
Antipsicóticos/uso terapéutico , Dibenzotiazepinas/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/fisiopatología , Urea/análogos & derivados , Estimulación Acústica/métodos , Adolescente , Adulto , Mapeo Encefálico , Peróxido de Carbamida , Corteza Cerebral/irrigación sanguínea , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/fisiopatología , Cognición/efectos de los fármacos , Combinación de Medicamentos , Femenino , Lateralidad Funcional/fisiología , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Peróxidos/sangre , Fumarato de Quetiapina , Tiempo de Reacción/efectos de los fármacos , Urea/sangre , Aprendizaje Verbal/efectos de los fármacos
3.
Am J Psychiatry ; 160(8): 1413-20, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12900302

RESUMEN

OBJECTIVE: Atypical antipsychotic drug treatment is clinically effective with a low risk of extrapyramidal symptoms. Explanations for the mechanism underlying this beneficial therapeutic profile of atypical over typical antipsychotic agents include 1) simultaneous antagonism of dopamine D(2) and serotonin 5-HT(2A) receptors or 2) selective action at limbic cortical dopamine D(2)-like receptors with modest striatal D(2) receptor occupancy. Amisulpride is an atypical antipsychotic drug with selective affinity for D(2)/D(3) dopamine receptors and provides a useful pharmacological model for examining these hypotheses. The authors' goal was to evaluate whether treatment with amisulpride results in "limbic selective" D(2)/D(3) receptor blockade in vivo. METHOD: Five hours of dynamic single photon emission tomography data were acquired after injection of [(123)I]epidepride (approximately 150 MBq). Kinetic modeling was performed by using the simplified reference region model to obtain binding potential values. Estimates of receptor occupancy were made relative to a healthy volunteer comparison group (N=6). RESULTS: Eight amisulpride-treated patients (mean dose=406 mg/day) showed moderate levels of D(2)/D(3) receptor occupancy in the striatum (56%), and significantly higher levels were seen in the thalamus (78%) and temporal cortex (82%). CONCLUSIONS: Treatment with amisulpride results in a similar pattern of limbic cortical over striatal D(2)/D(3) receptor blockade to that of other atypical antipsychotic drugs. This finding suggests that modest striatal D(2) receptor occupancy and preferential occupancy of limbic cortical dopamine D(2)/D(3) receptors may be sufficient to explain the therapeutic efficacy and low extrapyramidal symptom profile of atypical antipsychotic drugs, without the need for 5-HT(2A) receptor antagonism.


Asunto(s)
Antipsicóticos/uso terapéutico , Benzamidas , Antagonistas de los Receptores de Dopamina D2 , Radioisótopos de Yodo , Sistema Límbico/efectos de los fármacos , Sistema Límbico/diagnóstico por imagen , Pirrolidinas , Esquizofrenia/tratamiento farmacológico , Sulpirida/análogos & derivados , Sulpirida/uso terapéutico , Tomografía Computarizada de Emisión de Fotón Único , Adulto , Amisulprida , Antipsicóticos/metabolismo , Antipsicóticos/farmacología , Benzamidas/metabolismo , Cuerpo Estriado/diagnóstico por imagen , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Femenino , Humanos , Radioisótopos de Yodo/metabolismo , Sistema Límbico/metabolismo , Masculino , Persona de Mediana Edad , Pirrolidinas/metabolismo , Receptores de Dopamina D2/metabolismo , Receptores de Dopamina D3 , Esquizofrenia/metabolismo , Sulpirida/metabolismo , Sulpirida/farmacología , Lóbulo Temporal/diagnóstico por imagen , Lóbulo Temporal/efectos de los fármacos , Lóbulo Temporal/metabolismo , Tálamo/diagnóstico por imagen , Tálamo/efectos de los fármacos , Tálamo/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA